---
title: "Sanyou Medical: Joint venture company products pass the special review procedure for innovative medical devices"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258318259.md"
description: "Sanyou Medical announced that its joint venture Chuncheng Huayu's spinal surgery robot and related products have passed the special review process for innovative medical devices by the National Medical Products Administration and have been named the Spinal Surgery Navigation and Positioning System. This marks another important milestone for Sanyou Medical in innovative research and development. The approval of this product will accelerate its market launch and have a positive impact on the company's business"
datetime: "2025-09-22T09:39:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258318259.md)
  - [en](https://longbridge.com/en/news/258318259.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258318259.md)
---

# Sanyou Medical: Joint venture company products pass the special review procedure for innovative medical devices

According to the Zhitong Finance APP, Sanyou Medical (688085.SH) announced that its incubated and invested joint venture company, Chunchun Huayu (Suzhou) Intelligent Medical Technology Co., Ltd. (referred to as "Chunchun Huayu"), has recently passed the special review procedure for innovative medical devices by the National Medical Products Administration's Medical Device Technology Review Center for its spinal surgery robot and related intelligent products, which have been named the Spinal Surgery Navigation and Positioning System.

This approval for Chunchun Huayu's product to enter the innovative channel marks another important milestone in Sanyou Medical's innovative R&D system for 2025. Previously, another subsidiary of the company, Suzhou Yunhejing New Materials Technology Co., Ltd., developed the "Surface Porous Polyether Ether Ketone Interbody Fusion Device," which entered the innovative channel in April 2025. This product is undergoing the special review procedure for innovative medical devices and will receive priority processing rights during the registration application, effectively shortening the product registration cycle and accelerating the product's market launch speed. If this product is approved for market launch, it will further promote the use and marketing of related products under the innovative channel, positively impacting the company's business

### Related Stocks

- [688085.CN](https://longbridge.com/en/quote/688085.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Scott Jennings voices concern over Trump's $1.7B DOJ fund](https://longbridge.com/en/news/286922300.md)
- [World is more vulnerable to pandemics despite Covid-19 lessons, warns WHO](https://longbridge.com/en/news/286895865.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [Trump Delivers Confused Rambling After Claiming ’Every Agency' Has 'Scum'](https://longbridge.com/en/news/287086760.md)